Background
==========

One well known drawback of case-control study design in genetic association studies is that it may be affected by population stratification. Population stratification is an ethnic confounder. If a sample population is from a recent mixture of different ethnic subpopulations, it may make the cases and controls have different genetic background and spurious association may occur. In order to control the effect of population stratification, genome control \[[@B1]\], structured association \[[@B2]\], and principal components \[[@B3]\] are usually used. These methods try to gather information on population structure from markers not associated with the phenotype (null markers). In this paper, we introduce a likelihood-ratio test for genetic association in the presence of population stratification. This method does not make assumptions on the number of sub-populations in cases or in controls, nor does it make use of null markers. This method is then applied to the Genetic Analysis Workshop 16 (GAW16) Problem 1 data set.

Methods
=======

Let FST denote the correlation of alleles drawn from a common subpopulation \[[@B4]\]. FST is the proportion of the total heterozygosity in the population due to the differences in allele frequencies among each subpopulation. It can be expressed as F[ST]{.smallcaps} = , where is the average allele frequency over all subpopulations and *V*(*p*) is the variance of allele frequency *p*among subpopulations. The genotype frequencies in a population are jointly determined by F[ST]{.smallcaps} and the frequency of a reference allele, say *A*. We treat cases as samples from one population and controls as samples from another. Let *F*~1~be the value of F[ST]{.smallcaps} in cases and *F*~2~be the value of F[ST]{.smallcaps} in controls. The *A*allele frequency in cases and in controls are denoted by *p*~1~and *p*~2~, respectively. Let *a*denotes the other allele, the frequencies of genotypes *AA*, *Aa*, and *aa*in cases and controls are presented in Table [1](#T1){ref-type="table"}.

###### 

Genotype frequencies in cases and controls

             *AA*                                        *Aa*                                   *aa*
  ---------- ------------------------------------------- -------------------------------------- -----------------------------------------------------
  Cases      *p*~12~= *F*~1~*p*~1~+(1-*F*~1~)*p*~1~^2^   *p*~11~= 2(1-*F*~1~)*p*~1~(1-*p*~1~)   *p*~10~*= F*~1~*(*1-*p*~1~)+(1-*F*~1~)(1-*p*~1~)^2^
  Controls   *P*~22~= *F*~2~*p*~2~+(1-*F*~2~)*p*~2~^2^   *p*~21~= 2(1-*F*~2~)*p*~2~(1-*p*~2~)   *p*~20~*= F*~2~(1-*p*~2~)+(1-*F*~2~)(1-*p*~2~)^2^

We proposed a likelihood ratio test to test the hypotheses H0: *p*~1~= *p*~2~= *p*, *F*~1~, *F*~2~versus H~*A*~: *p*~1~≠ *p*~2~, *F*~1~, *F*~2~. *F*~1~and *F*~2~are treated as nuisance parameters. The log-likelihood function is

in which *i*= 1 or 2 for cases or controls; for each marker genotype, *j*= 0, 1, or 2 for zero *A*allele, one *A*allele, or two *A*alleles, respectively. *n*~*ij*~are observed genotype counts and *p*~*ij*~are genotype frequencies as listed in Table [1](#T1){ref-type="table"}.

The maximization of the likelihood function *L*(*p*~1~, *p*~2~, *F*~1~, *F*~2~) under the alternative hypothesis is straightforward. The maximized estimate of each genotype frequency happens to be the observed genotype frequency in cases and controls. However, there is no explicit solution to the maximization problem under the null hypothesis. To maximize the log-likelihood function under H~0~, we take the first-order partial derivatives of the log-likelihood function under the null with respect to *F1*and *F2*and set them to zero. Each of the two equations gives an expression of *F1*or *F2*in terms of *p*. Then a grid search (step size 0.001) over *p*ranging from 0.001 to 0.999 is used to find the best value of *p*maximizing the null log-likelihood function.

The likelihood ratio test statistic is

According to standard statistical theory, it asymptotically follows a chi-square distribution with 1 degree of freedom.

Results
=======

The GAW16 Problem 1 data set consists of 545,080 SNP markers throughout the genome for 2062 unrelated individuals consisting of 868 patients with rheumatoid arthritis and 1194 controls. After quality control, 65,372 (11.99%) markers were removed. A marker was removed if it met any one of the following criteria: its call rate was less than 90%; the minor allele frequency was less than 0.01, or it did not follow Hardy-Weinberg equilibrium in controls (at significance level 0.05). In addition, we only considered markers on autosomal chromosomes. Finally, 466,317 markers were included for further study. Transformed *p*-values (-log~10~(*p*)) were plotted genome-wide in Figure [1](#F1){ref-type="fig"} (top panel) by using the *Haploview*program. In addition, for comparison, results from traditional Pearson chi-square test were also plotted (Figure [1](#F1){ref-type="fig"}, bottom panel). Figure [2](#F2){ref-type="fig"} plots the transformed *p*-values for the proposed test versus that for the Pearson chi-square test. The left-most panel includes all markers. The middle panel includes only those markers for which the absolute value of the difference in the estimated *F*~1~and *F*~2~is larger than or equal to 0.05. The right-most panel includes markers with difference between *F*~1~and *F*~2~less than 0.001. If the difference is within 0.001, we treat *F*~1~and *F*~2~are approximately equal. When the difference between *F*~1~and *F*~2~becomes larger, the proposed test statistic tends to be less significant.

![**Plots of transformed *p*-values for the new test and Pearson chi-square test**.](1753-6561-3-S7-S111-1){#F1}
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Discussion
==========

We proposed a test for genetic association study in the presence of population stratification. Population stratification is a confounder to the difference of genotype frequencies between cases and controls. Unlike some other methods such as the structured association, the proposed test does not try to classify each individual. Instead, it allows for the difference in the composition of cases and controls by using two of FST coefficients, one for cases and one for controls. Population genetics suggests that the FST for a natural population may be small (for instance, 0.001 or 0.01). This may be true for controls, but no longer true for a selected sample such as cases. It is easy to construct a case sample for which the FST is 0.8 or higher. Our test provides a simple way to reduce the confounding impact of population stratification compared with the Pearson chi-square statistic.

The proposed method attributes any deficiency in heterozygosity in cases or controls to population stratification. Its power to detect association can be compromised when there is no population stratification, especially when the trait is recessive \[[@B5]\]. Because population stratification affects not only FST but also allele frequencies in cases and controls, the proposed method cannot completely eliminate the confounding effect of population stratification. Due to the page limitation, no simulation results comparing the proposed method and the Pearson\'s chi-square statistic are reported. One reviewer pointed out that this may make it difficult to interpret the difference between these two methods observed in current study. In our unreported simulation studies, the proposed method is still more robust to population stratification than Pearson\'s chi-square statistic.

Conclusion
==========

A method for detecting association in the presence of population stratification is proposed. Analysis of the GAW16 Problem 1 data on rheumatoid arthritis suggests it is more robust to population stratification than the Pearson\'s chi-square statistic. The proposed test is implemented in two computer languages, *C++*and *R*. Both versions are available from the authors upon request.
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